index - Génétique et physiopathologie des MNM liées à la matrice extracellulaire et du noyau

Dernières publications

Chiffres clés

121 Publications avec texte intégral
1 Données de recherche

Open Access

48 %

Mots clés

Therapy Laminopathie Lamins GNE Laminopathies Dilated cardiomyopathy Butyrylcholinesterase Allele-specific silencing COVID-19 Actionable gene POPDC1 Angiotensin-converting enzyme inhibitor Muscle biopsy AAV VECTOR Dystrophie musculaire Rare diseases Lamin A/C A-type lamin Errance diagnostique Maladies rares et orphelines Myopathies LMNA gene Muscular dystrophy Biomarker Lamin A/C LMNA gene Myotubes Rare neuromuscular diseases CRISPR Centronuclear myopathy Calcium handling Clinical trial Cardiology Autophagosome maturation Myologie Mouse Myopathy Allele-specific silencing therapy C elegans Angiotensin-converting enzyme inhibitors Biological sciences Regeneration Hypermobile EDS Titin Adult SMA Neuromuscular diseases Dynamin 2 Congenital muscular dystrophy BVES Next generation sequencing Cancer Muscle MRI AAV Heart LGMD Duchenne muscular dystrophy A-type lamins COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders Mutations CMTX Becker muscular dystrophy LMNA Ehlers‐Danlos Syndrome Myogenesis Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Allele‐specific silencing therapy Heart failure Actionability Exome Nuclear envelope INPP5K Cancer biomarkers COL1A1 Maladies rares Emery-Dreifuss muscular dystrophy Base de données FAIR Diagnosis Lamin A/C nuclei Joint laxity RNA interference Cardiac conduction system Emerin Muscle Patient registry Treatment Connective tissue Dystrophine Acetyltransferase Alternative splicing Laminopathy Skeletal muscle Gene therapy BiP IPSC C2C12 Cardiomyopathy Muscular dystrophy MD Treatment delay LMNA-related congenital muscular dystrophy COL6A1 CSF protein